Quinoxaline - CAS 91-19-0
Catalog: |
BB040077 |
Product Name: |
Quinoxaline |
CAS: |
91-19-0 |
Synonyms: |
1,4-Benzodiazine; 1,4-Diazanaphthalene; 1,4-Naphthyridine; Benzo[a]pyrazine; Benzoparadiazine; Benzopyrazine; Phenopiazine; Phenpiazine; Quinazine |
IUPAC Name: | quinoxaline |
Molecular Weight: | 130.15 |
Molecular Formula: | C8H6N2 |
Canonical SMILES: | C1=CC=C2C(=C1)N=CC=N2 |
InChI: | InChI=1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H |
InChI Key: | XSCHRSMBECNVNS-UHFFFAOYSA-N |
Boiling Point: | 220-223°C |
Melting Point: | 28-34°C |
Purity: | 95% |
Density: | 1.183±0.06 g/cm3 |
Appearance: | Yellow solid |
Storage: | Keep away from sources of ignition. Store in a cool, dry place. Store in a tightly closed container. |
MDL: | MFCD00006719 |
LogP: | 1.62980 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021104678-A1 | Organic compound, electroluminescent material, and use thereof | 20200922 |
US-10882852-B1 | 3-vinylquinolines as cancer cells inhibitors | 20200709 |
US-2020392165-A1 | Compound, display panel and display apparatus | 20200630 |
US-2020395554-A1 | Compound and organic electro-optical device containing the same | 20200515 |
US-11015113-B1 | Wet-coated proppant and methods of making and using same | 20200413 |
PMID | Publication Date | Title | Journal |
34189909 | 20210719 | Mechanism-Based Inactivation of Cytochrome P450 3A4 and 3A5 by the Fibroblast Growth Factor Receptor Inhibitor Erdafitinib | Chemical research in toxicology |
33986405 | 20210513 | Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase | Scientific reports |
31893549 | 20200215 | Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme | European journal of medicinal chemistry |
31283223 | 20190808 | Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series | Journal of medicinal chemistry |
31086981 | 20190801 | Quizalofop-p-Ethyl Induces Adipogenesis in 3T3-L1 Adipocytes | Toxicological sciences : an official journal of the Society of Toxicology |
Complexity: | 99.8 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 130.053098200 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 130.053098200 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS